Danny Alon Ellenbogen, MD CV updated August 2017 1/
CURRICULUM VITAE
Name: Danny Alon Ellenbogen, MD ID No.: 029436201
Faculty/Dept: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel/ Internal Medicine
Hospital/Dept: Department of Internal Medicine B Rabin Medical Center – Beilinson Hospital Petach Tikva 4941492, Israel
Email: [email protected]
Date & Place of Birth: September 16, 1972, Israel
ZAHAL (Israeli) Mar 1998 July 2002 RANK: MAJOR, ISRAEL AIR FORCE Military Service: (Enlisted) (Discharged)
Marital Status: Married, 2 children
A. EDUCATION PERIODS OF STUDIES
1990-1996 Hebrew University – Hadassah Medical School, Jerusalem, Israel Subject: Medicine
MD degree Title of Doctoral Dissertation: Symptomatology in carriers of type 1 Gaucher disease Supervised by: Prof. Ari Zimran, MD MD License No.: 30090
Danny Alon Ellenbogen, MD CV updated August 2017 2/
C. ACADEMIC & PROFESSIONAL ACTIVITIES & ACHIEVEMENTS
C1. Academic Experience:
2004, 2011 Tutor [Internal Medicine] to 4th and 6th year medical students, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2005, 2011 Tutor [Internal Medicine] to 3rd and 4th year medical students of the American program, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2005, 2011 Instructor, internal medicine residents, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2008-2010 Co-Moderator of the Travel Medicine Internet Site and Q&A Forum, Clalit Health Services and Tapuz Travel Health Forum
2009 Writing and instructing the Endocrinology Course, Meir Medical Center School of Nursing, Kfar Saba, Israel
2009 Lecturer [Infectious Diseases], Pre-clinical 4th year medical course
2011-2013 Team member of final internal medicine examination constructing committee [Head: Prof. Yair Levi], Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2013 Lecturer [HIV], Tel Aviv University Internal Medicine Postgraduate Studies
10-11/2014 Team member of step B Internal Medicine Specialty Board Committee, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
10-12/2014, Team member of step B Infectious Diseases Specialty Board 10-12/2015, Committee, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 10-12/2016 Israel
Ongoing Instructor [Internal Medicine], 4th and 6th year medical students, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Since 2014 Lecturer [Internal Medicine], Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Danny Alon Ellenbogen, MD CV updated August 2017 3/
C2. Professional Experience:
1997-1998 Internship, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
2002-2006 Resident in Internal Medicine, Department of Internal Medicine B, Meir Medical Center, Kefar Saba, Israel [Prof. Josef Mekori]
Title of Scientific Dissertation: Assessment of platelet adhesion and aggregation in fresh and stored blood products using the cone and platelet analyzer Supervised by: Martin Ellis, MD
2006-2008 Infectious Diseases Fellowship, Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel [Michal Chowers]
2008-2010 Senior Physician, Department of Medicine D, Meir Medical Center, Kfar Saba, Israel
2010-2011 Senior Physician, Infectious Diseases Unit and AIDS Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2011-present Senior Physician, Department of Internal Medicine B, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
2011-present Senior Physician, HIV Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and Travel Medicine Clinic, Meir Medical Center, Kfar Saba, Israel
Military Service:
1998-2000 Medical Officer, Military Engineering Regiment 200-2001 Clinic Commander, School of Military Engineering 2001-2002 Public Appeals Officer, Israeli Medical Corps 2001-2017 Reserve Medical Officer, Anti-Missile Unit, Israel Air Force
Courses
2009 Good Clinical Practice
Danny Alon Ellenbogen, MD CV updated August 2017 4/
C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS
Date Country Name of Meeting Role
19th European Congress of Clinical 2009 Helsinki, Finland Oral Presentation Microbiology & Infectious Diseases
Israel Society for Parasitology, Protozoology & 2010 Ramat Gan, Israel Oral Presentation Tropical Diseases (SPPTD) Conference
2013 Brussels, Belgium 14th European AIDS Conference (EACS) Poster
2013 Jerusalem, Israel Israeli Heart Society (HIS) Conference Oral Presentation
International Workshop on Antiviral Drug 2014 Berlin, Germany Poster Resistance
C4. MEMBERSHIP IN PROFESSIONAL SOCIETIES
Years (period) Name of Organization 2006-present Israel Society for Infectious Diseases European Society of Clinical Microbiology and Infectious
Diseases (ESCMD) Israel Society of Internal Medicine 2006-2013 Israel Society for Tropical Medicine 2007-present Israeli AIDS Society European AIDS Clinical Society (EAS)
Danny Alon Ellenbogen, MD CV updated August 2017 5/
G. AWARDS
May 2000 Received Chief Medical Corps Officer’s Excellence Award, Israel Independence Day
Danny Alon Ellenbogen, MD CV updated August 2017 6/
SCIENTIFIC PUBLICATIONS
B.1. ORIGINAL ARTICLES
B.1. Articles Published
1. Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17(4):250-255. (MEDICINE, GENERAL & INTERNAL 58/154, Q2, IF 1.803, Cited 19)
2. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended- spectrum beta-lactamases. Antimicrob Agents Chemother. 2010;54(12):5099-5104. (PHARMACOLOGY & PHARMACY 36/256, Q1, IF 4.302, Cited 54)
3. Alon D, Abd-Elkadir F, Chowers M, Paitan Y. MRSA SCCmec epidemiology in Israel: Development and implementation of an MRSA SCCmec typing strategy. Eur J Clin Microbiol Infect Dis. 2011;30(11):1443-52. (INFECTIOUS DISEASES 38/84, Q2, IF 2.727, Cited 5)
4. Schechner V, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Finkelstein R, Lachish T, Wiener-Well Y, Alon D, Chowers M, Bardenstein R, Zimhony O, Paz A, Potasman I, Giladi M, Schwaber MJ, Klarfeld-Lidji S, Hochman M, Marchaim D, Carmeli Y. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy. Diagn Microbiol Infect Dis. 2011;7(1):38-45. (MICROBIOLOGY 64/124, Q3, IF 2.401, Cited 13)
5. Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev. 2011;10(8):490-494. (IMMUNOLOGY 11/150, Q1, IF 8.961, Cited 64)
Danny Alon Ellenbogen, MD CV updated August 2017 7/ B.1. Articles Published
6. Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013;8(8):e72476. (MULTIDISCIPLINARY SCIENCES 15/64, Q1, IF 2.806, Cited 7)
7. Stein GY, Ben-Gal T, Kremer A, Bental T, Alon D, Korenfeld R, Yedidia I, Porter A, Abramson E, Sagie A, Fuchs S. Gender-related differences in hospitalized heart failure patients. Eur J Heart Fail. 2013;15(7):734-741. (CARDIAC & CARDIOVASCULAR SYSTEMS 12/126, Q1, IF 6.968, Cited 9)
8. Avidor B, Girshengorn S, Matus N, Talio H, Achsanov S, Zeldis I, Fratty IS, Katchman E, Brosh-Nissimov T, Hassin D, Alon D, Bentwich Z, Yust I, Amit S, Forer R, Vulih Shultsman I, Turner D. Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory. J Clin Microbiol. 2013;51(3):880-886. (MICROBIOLOGY 33/124, Q2, IF 3.712, Cited 17)
9. Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, Gevrielov-Yusim N, Iakobishvili Z, Fuchs S. Type-II myocardial infarction--patient characteristics, management and outcomes. PLoS One. 2014; Jan 2;9(1):e84285. (MULTIDISCIPLINARY SCIENCES 15/64, Q1, IF 2.806, Cited 22)
10. Obolski U*, Alon D*, Hadany L, Stein G. Resistance Profiles of CoNS Contaminating Blood Cultures Predict Pathogen Resistance and Patient Mortality. [*Equal contribution] J Antimicrob Chemother. 2014 Sep;69(9):2541-6. (PHARMACOLOGY & PHARMACY 23/256, Q1, IF 5.071, Cited 0)
11. Stein GY, Alon D, Korenfeld R, Fuchs S. Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patients. PLoS One. 2015 Jan 30;10(1):e0117162. (MULTIDISCIPLINARY SCIENCES 15/64, Q1, IF 2.806, Cited 2)
12. Oz N, Alon D, Chezar-Azerrad C, Cooper L, Levi Y, Fuchs S, Stein GY. Estimating Risk of Venous-Thromboembolic Events in Hospitalized Medical Patients: Comparison between 2008 and 2012 Guidelines. Isr Med Assoc J. 2016 Jun;18(6):346-9. (MEDICINE, GENERAL & INTERNAL 98/154, Q3, IF 1.036, Cited 0)
Danny Alon Ellenbogen, MD CV updated August 2017 8/ B.1. Articles Published
13. Alon D, Stein GY, Hadas-Golan V, Tau L, Brosh T, Turner D. Immunogenicity of Sci-B-Vac (a Third-Generation Hepatitis B Vaccine) in HIV- Positive Adults. Isr Med Assoc J. 2017 Mar;19(3):143-146. (MEDICINE, GENERAL & INTERNAL 98/154, Q3, IF 1.036, Cited 0)
14. Oz N, Alon D, Stein GY, Turner D. Adherence and Characteristics of HIV Post-Exposure Prophylaxis for a Population in Tel Aviv of Men who have Sex with Men. Isr Med Assoc J. 2017 Apr;19(4):257-261. (MEDICINE, GENERAL & INTERNAL 98/154, Q3, IF 1.036, Cited 0)
"The no. of articles marked Q1 7 out of no. of total articles /articles from "line – drawn" of last process 14 ."
מאמרים שפורסמו בעיתונים המדורגים כיום ברביע העליון (Q1) בתחומם, מאז המינוי האחרון
מס' מאמר IF ו-Q )כפי IF ו-Q שם העיתון שנת פרסום בשנת שמופיע ב- כיום CV( פרסום IF 4.302 IF 4.672 2202 Antimicrobial agents & Chemotherapy .2 Q1 Q1 IF 8.961 IF 6.624 2200 Autoimmunity Reviews .5 Q1 Q1 IF 2.806 IF 3.534 2202 PLoS One .6 Q1 Q1 IF 6.968 IF 6.577 2202 European Journal of Heart Failure .7 Q1 Q1 IF 2.806 IF 3.234 2202 PLoS One .9 Q1 Q1 IF 5.071 IF 5.313 2202 Journal of Antimicrobial Chemotherapy .02 Q1 Q1 IF 2.806 IF 3.057 2205 PLoS One .00 Q1 Q1
Danny Alon Ellenbogen, MD CV updated August 2017 9/ B.2. CASE REPORTS
B.2. Case Reports Published
1. Alon D, Chowers M. Successful therapeutic splenectomy in an HIV patient with relapsing visceral leishmaniasis. Int J STD AIDS. 2012; 23: 289-290.
2. Alon D, Ben-Nissan Y, Paitan Y, Chowers M. Persistent Helicobacter canis bacteremia in a patient with gastric lymphoma. Infection. 2010;38: 62-64.
B.2. Case Reports Published
3. Kugler E, Amital H, Alon D. Fever in pregnancy— case presentation and literature review. Int J Clin Med. 2013; 4: 364-368.
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS
1. Alon D, Chowers M. Successful therapeutic splenectomy for relapsing visceral leishmeniasis in an HIV patient. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 2009.
2. Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. Israel Society for Parasitology, Protozoology and Tropical Diseases (ISPPTD), Kfar Hamacabbia, Ramat Gan, Israel, December 2010.
3. Alon D, Stein G, Hadas-Golan V, Tau L, Wasserman A, Hassin D, Turner D. Immunogenicity of Sci-B-Vac (a 3rd generation hepatitis B vaccine) in HIV- positive adults. 14th European AIDS Conference (EACS), Brussels, Belgium, October 2013.
4. Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. Israeli Heart Society Conference, Jerusalem, Israel, December 2013.
Danny Alon Ellenbogen, MD CV updated August 2017 10/ D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS
5. Turner D, Tau L, Alon D, Katzman E. Avidor B. Prevalence of transmitted HIV-1 drug resistance in Tel-Aviv, Israel, from 2010- 2013. International Workshop on Antiviral Drug Resistance, Berlin, Germany, June 2014.